Aberrant signaling pathways in pancreatic cancer: a two compartment view.
about
Pancreatic cancerSIBLINGs and SPARC families: their emerging roles in pancreatic cancerTargeted destruction of the orchestration of the pancreatic stroma and tumor cells in pancreatic cancer cases: molecular basis for therapeutic implicationsZebrafish reporter lines reveal in vivo signaling pathway activities involved in pancreatic cancer.Molecular Drivers of Pancreatic Cancer Pathogenesis: Looking Inward to Move Forward.Targeting inhibitors of the tumor suppressor PP2A for the treatment of pancreatic cancerSuppression of cholangiocarcinoma cell growth by human umbilical cord mesenchymal stem cells: a possible role of Wnt and Akt signaling.Tumor necrosis factor induces tumor promoting and anti-tumoral effects on pancreatic cancer via TNFR1.Pancreatic cancer stromal biology and therapy.Integrated Genomic Analysis of Pancreatic Ductal Adenocarcinomas Reveals Genomic Rearrangement Events as Significant Drivers of DiseaseIntegrated stress response is critical for gemcitabine resistance in pancreatic ductal adenocarcinomaBayesian model of signal rewiring reveals mechanisms of gene dysregulation in acquired drug resistance in breast cancerThe implications of cancer stem cells for cancer therapy.Pancreatic cancer-associated retinoblastoma 1 dysfunction enables TGF-β to promote proliferation.Oxidative stress in apoptosis and cancer: an update.Tumor budding cells, cancer stem cells and epithelial-mesenchymal transition-type cells in pancreatic cancer.SOX15 is a candidate tumor suppressor in pancreatic cancer with a potential role in Wnt/β-catenin signaling.Translational molecular imaging in exocrine pancreatic cancer
P2860
Q27005724-F8ECB79D-1901-45FB-AEE9-11DE3390EF8CQ27027759-C00ECC99-7415-45F7-B859-99D3A22B4643Q28269990-306DD9FA-BD61-4A6E-A75D-56053980A0E7Q30581795-839053B2-D35C-4F4B-B923-62FFC5B7B51AQ33624574-BCDF321D-6D4D-4610-BB24-1309D5E7F2C0Q33977247-CCC8ABD7-A984-4779-A68A-5D621DD1010BQ34706869-F1DD9E7C-3071-4AD7-922A-9E436A125CA7Q35010079-2AAC8876-78C2-4636-8DAC-F7F46DE1142FQ35766799-F29FE96E-579C-4486-9AA5-5D6F587B280BQ35871175-0FD94603-005C-4FFD-ACC6-3EA897F69526Q36246425-AAC5A0CF-4571-4B93-A260-EF40EDB4D3DFQ36306149-7440BECE-CE13-4D38-8813-14CFC7A6F0B5Q36538487-01960F08-4268-4286-A0B0-33729E2DDF27Q37410628-B76996FF-8BFD-4206-A285-ACE8DCD01100Q38027434-507F0874-96E7-4B7F-9D15-C1B186591F6AQ38073775-4FD06E19-DBAB-4A69-9745-4CF4C5011743Q39210861-0182CD40-1632-47FB-8D66-82547E1C219BQ58728351-6EE214E0-0096-4159-9FFB-1AFF35C261ED
P2860
Aberrant signaling pathways in pancreatic cancer: a two compartment view.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Aberrant signaling pathways in pancreatic cancer: a two compartment view.
@ast
Aberrant signaling pathways in pancreatic cancer: a two compartment view.
@en
type
label
Aberrant signaling pathways in pancreatic cancer: a two compartment view.
@ast
Aberrant signaling pathways in pancreatic cancer: a two compartment view.
@en
prefLabel
Aberrant signaling pathways in pancreatic cancer: a two compartment view.
@ast
Aberrant signaling pathways in pancreatic cancer: a two compartment view.
@en
P2093
P2860
P356
P1476
Aberrant signaling pathways in pancreatic cancer: a two compartment view.
@en
P2093
Angela L McCleary-Wheeler
Martin E Fernandez-Zapico
Robert McWilliams
P2860
P356
10.1002/MC.20827
P577
2012-01-01T00:00:00Z